Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients
KD Steffensen, M Waldstrøm, I Brandslund… - International Journal of …, 2011 - ijgc.bmj.com
Objective: Human epididymis protein 4 (HE4) has attracted a lot of interest as a relatively
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients
KD Steffensen, M Waldstrøm… - … : official journal of …, 2011 - pubmed.ncbi.nlm.nih.gov
Objective Human epididymis protein 4 (HE4) has attracted a lot of interest as a relatively
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
[PDF][PDF] Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients
KD Steffensen, M Waldstrøm, I Brandslund… - Int J Gynecol …, 2011 - academia.edu
Objective: Human epididymis protein 4 (HE4) has attracted a lot of interest as a relatively
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients
KD Steffensen, M Waldstrøm… - International …, 2011 - portal.findresearcher.sdu.dk
Abstract Human epididymis protein 4 (HE4) has attracted a lot of interest as a relatively
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
[引用][C] Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients
KD Steffensen, M Waldstrøm, I Brandslund… - International Journal of …, 2011 - cir.nii.ac.jp
Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian
Cancer Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Cancer Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients
KD Steffensen, M Waldstrøm… - International …, 2011 - search.proquest.com
Objective: Human epididymis protein 4 (HE4) has attracted a lot of interest as a relatively
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients.
KD Steffensen, M Waldstrøm, I Brandslund… - … : Official Journal of the …, 2011 - europepmc.org
Objective Human epididymis protein 4 (HE4) has attracted a lot of interest as a relatively
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients
KD Steffensen, M Waldstrøm… - International …, 2011 - findresearchersdu.elsevierpure.com
Abstract Human epididymis protein 4 (HE4) has attracted a lot of interest as a relatively
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …
novel biomarker for ovarian carcinoma. Research focus has been directed at HE4 as a …